TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer.

Amanda N Ruggieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.